Greetings Junebug! I always like your down home look at
Greetings Junebug! I always like your down home look at life!
I have all my shares, lol. I don't know if I could be considered "loyal". I have other stocks in which I have a much larger basis than UNVC. I won't "pump or promote" UNVC and I won't share with people I care about until we have more facts. I also won't bash or try to sway anyone's opinion regarding UNVC. I will only analyze UNVC on a daily basis and give an honest answer to questions when asked.
Board research has shown many reasons for being loyal but the OTC has a history of CEO's and stocks that are great at creating an illusion. Many promise far more than they return. SLJB and KMAG are two stocks where the CEO's were promising huge returns and board research pointed that direction. Both stocks had "insider" shareholders with personal knowledge that spoke frequently with the CEO. After the said promises ran out, both stocks suffered price collapses. I'm sure it was financially painful for many. There are a litany of such stories in Pinksheet quoted stocks.
We're a Pinksheet quoted stock, that is Dark.
UNVC is and has remained "dark" for a decade. The reason, disposable needle competitors "screwed" UNVC out of revenue and contracts. I've read all of Dr. Daltons Tweets several times but still feel very leery of getting in all the way, too risky.
If we're a conglomerate, why not go current with a small section of the business and reveal the share structure and show modest revenue. Dr. Dalton could keep the bulk of the conglomerate as secret as what we have now. That would create greater shareholder confidence and wider spread interest. Then adding in all the ancillary portions of the conglomerate would accomplish the same thing. Instead, we get to interpret dots, tweets and stealthy LinkedIn posts.
I sincerely wish everyone holding UNVC stock the very best. I hope it is life changing in a positive way for everyone. I hope many here receive the resources to bless many lives well beyond their own.
Yes, I still own all my shares and hope. I also still own all my doubts. Two decades in the OTC's makes one a very leery investor.
5
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Teamsters Prep for Possible Strike Against US Foods You can almost hear the union drums beating as 260 drivers from Teamsters Local 282 in New York gear up for what could be a major confrontation with US Foods. The message is loud and clear: pay us what we're worth, or watch your delivery chain grind to a halt. With unanimous approval to strike, this isn't just a...
Continue Reading
Resource Expansion at the Shaakichiuwaanaan Property You ever see a resource report that makes you do a double take? That's the vibe here with PMET's game-changing update on their Shaakichiuwaanaan property in Quebec. They've crunched the numbers at the Helios Caesium Zone and CV4 Pegmatite, and the results? A juicy increase in the grade, scale, and tonnage across three...
Continue Reading
GNSS Simulator Market: Gadgets Meet Growth A market that's been quietly bubbling away on the back burner is about to boil over: The GNSS Simulator Market, pegged at a neat $424.6 million by 2031. Yeah, it might be niche, but those in the know can't get enough of these satellite-signal replicators. Why GNSS Simulators are Crushing It There's a bunch of reasons why GNSS...
Continue Reading
Mobilizing Aid: A Community in Crisis Not every day you wake up to a story that digs into your gut like this one. The folks at the Green Acres Mobile Home Community in Palm Beach County got dealt a raw deal. A Learjet crash shook their world apart on November 1st, leaving nine lives lost on that flight and sending hundreds of residents scrambling from their homes. It's a...
Continue Reading
Indonesia's Burning Questions There's been a lot of smoke—literally and figuratively—hanging over the palm oil industry in Indonesia this year. At the RSPO's Annual Roundtable on Sustainable Palm Oil (RT2026), attendees didn't shy away from addressing the harsh realities. In a year marked by rampant fires, thanks to the blistering El Niño, the RSPO showcased data...
Continue Reading
When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...
Continue Reading
Shaping the Future with AI Integration In the whirlwind of innovation, there's always the ones braving the frontier, pushing the very boundaries of what we deem possible. Today, it's HashKey Capital and AMBR joining forces, marching into uncharted financial territories. This partnership is more than just a signature on a piece of paper; it's a declaration—a commitment...
Continue Reading
Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...
Continue Reading
Budget Pains for Silvercorp's El Domo Project Folks, if you thought navigating the stock market was a minefield, try mining these days. Silvercorp Metals Inc. had to bump up its budget for the El Domo project in Ecuador—again. This time by $14.6 million. What's causing this fiscal heartache? Everything from rising diesel prices thanks to Ecuador playing games with...
Continue Reading
A New Captain for BD's Peripheral Ship Time to pay attention, folks. Franklin Lakes just sent an interesting ripple through their workforce headlines, announcing Bridget Bagnato taking the reins as Worldwide President of BD's Peripheral Intervention division. Come November 16, this medical tech veteran, who's clocked over 27 years with BD, is set to start steering their...
Continue Reading
Top 5 Most Recently Viewed Articles
SEATOM's Selection for NATO's Accelerator Programme Today, SEATOM announced a significant milestone as it was chosen to participate in the NATO Defence Innovation Accelerator for the North Atlantic (DIANA) 2026 Challenge Programme. This prestigious selection underscores SEATOM's innovative approach to developing nuclear technology tailored for maritime and extreme...
Continue Reading
OpenAI Completes a Major Acquisition OpenAI has recently wrapped up a remarkable deal by acquiring Jony Ive's AI hardware startup, io Products, for a staggering $6.5 billion. This acquisition brings the design genius, renowned for his work at a major tech giant, into OpenAI's fold to help create a new generation of smart devices. Key Developments Post-Acquisition The...
Continue Reading
Opportunities for KinderCare Investors Robbins Geller Rudman & Dowd LLP has announced a significant opportunity for investors of KinderCare Learning Companies, Inc. (NYSE: KLC) who have experienced substantial losses. This is a pivotal moment for shareholders as they can now seek to lead a class action lawsuit against the company. Understanding the Class Action Lawsuit...
Continue Reading
Growth of Baltic Horizon Fund's NAV in May 2025 The Baltic Horizon Fund reported an increase in its net asset value (NAV) per unit, which rose to EUR 0.6757 at the close of May 2025. This figure represents a slight gain from the NAV of EUR 0.6740 recorded at the end of April 2025. The fund's overall net asset value reached EUR 97.0 million, up from EUR 96.8 million in the...
Continue Reading
Autolus Therapeutics Showcases CARLYSLE Trial Results Autolus Therapeutics plc (Nasdaq: AUTL), a biopharmaceutical leader in developing innovative T cell therapies, recently showcased promising preliminary data from the CARLYSLE trial, which focuses on severe refractory systemic lupus erythematosus (srSLE). The data were presented during a special session at a leading...
Continue Reading